TY - JOUR T1 - 2020 Year in Review: Pharmacologic Treatments for COVID-19 JF - Respiratory Care SP - 1167 LP - 1172 DO - 10.4187/respcare.09153 VL - 66 IS - 7 AU - Jessica L Saunders AU - Michael D Davis Y1 - 2021/07/01 UR - http://rc.rcjournal.com/content/66/7/1167.abstract N2 - Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infection, has led to a pandemic of acute respiratory illness. Pharmacologic treatments for COVID-19 have included treatments that target infection prevention, prevention of viral replication, reduce inflammation, and manage symptoms of respiratory failure caused by the disease. This is a review of key pharmacologic treatments for COVID-19 based on peer-reviewed articles from 2020. ER -